Shanghai Bao Pharmaceuticals Co (HKSE:02659) Notes Receivable: HK$0.00 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:02659 Shanghai Bao Pharmaceuticals Co Ltd HKSE:02659
9 GF Score
Price HK$15.94
! 2 Warning Signs
View Full Analysis

What is Shanghai Bao Pharmaceuticals Co Notes Receivable?

Shanghai Bao Pharmaceuticals Co HKSE:02659 +0.25% 9 Notes Receivable is HK$0.00 Mil as of Dec. 2025. GuruFocus rates HKSE:02659 with a GF Score™ of 9/100. The stock has 2 warning signs investors should review.

Shanghai Bao Pharmaceuticals Co's Notes Receivable for the quarter that ended in Dec. 2025 was HK$0.00 Mil.

Shanghai Bao Pharmaceuticals Co Notes Receivable Related Terms

Shanghai Bao Pharmaceuticals Co Notes Receivable Historical Data

* Premium members only.

The historical data trend for Shanghai Bao Pharmaceuticals Co's Notes Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shanghai Bao Pharmaceuticals Co Notes Receivable Chart

Shanghai Bao Pharmaceuticals Co Annual Data
Trend Dec23 Dec24 Dec25
Notes Receivable
0.00 0.00 0.00

Shanghai Bao Pharmaceuticals Co Semi-Annual Data
Dec23 Jun24 Dec24 Jun25 Dec25
Notes Receivable 0.00 0.00 0.00 0.00 0.00
HKSE:02659
9GF Score
Shanghai Bao Pharmaceuticals Co Ltd HKSE:02659
Notes Receivable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Shanghai Bao Pharmaceuticals Co Notes Receivable Calculation

Notes Receivable is an unconditional promise to receive a definite sum of money at a future date(s) within one year of the balance sheet date or the normal operating cycle, whichever is longer.

Frequently Asked Questions Learn more about Notes Receivable →
What does a Notes Receivable of HK$0.00 Mil mean?
Shanghai Bao Pharmaceuticals Co (HKSE:02659) has a Notes Receivable of HK$0.00 Mil as of Dec. 2025. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Shanghai Bao Pharmaceuticals Co and its competitors.
Is Shanghai Bao Pharmaceuticals Co's Notes Receivable too high?
Shanghai Bao Pharmaceuticals Co's current Notes Receivable is HK$0.00 Mil. Overall, Shanghai Bao Pharmaceuticals Co has a GF Score™ of 9/100, reflecting its overall financial health beyond just this single metric.
How does Shanghai Bao Pharmaceuticals Co's Notes Receivable compare to VRTX and REGN?
Shanghai Bao Pharmaceuticals Co's Notes Receivable of HK$0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Notes Receivable for a Biotechnology company?
A good Notes Receivable depends on the Biotechnology industry context. However, Notes Receivable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Notes Receivable mean?
A high Notes Receivable can signal that a stock is expensive relative to its fundamentals. Notes Receivable is an unconditional promise to receive a definite sum of money within one year. View historical data on Shanghai Bao Pharmaceuticals Co and its competitors. Shanghai Bao Pharmaceuticals Co's current Notes Receivable is HK$0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai Bao Pharmaceuticals Co stock overvalued right now?
Shanghai Bao Pharmaceuticals Co (HKSE:02659) has a current Notes Receivable of HK$0.00 Mil. The current Notes Receivable is HK$0.00 Mil. Shanghai Bao Pharmaceuticals Co's overall GF Score™ is 9/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Notes Receivable calculated?
Notes Receivable is calculated from a company's financial statements. For Shanghai Bao Pharmaceuticals Co (HKSE:02659), the current Notes Receivable is HK$0.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Shanghai Bao Pharmaceuticals Co Business Description

Address No. 28 Luoxin Road, Baoshan District, Shanghai, CHN
Shanghai Bao Pharmaceuticals Co Ltd is a biotechnology company with an approved product and a diverse clinical pipeline, leveraging synthetic biology technology to develop and deliver recombinant biologic drugs in China, targeting conditions with limited treatment options and complex manufacturing challenges. The company has proprietary technology platforms, supported by its chassis cell engineering technology, that combine drug design and bioprocessing capabilities. It has production lines for finished dosage forms, including injectable solutions, lyophilized powder injections, and pre-filled syringes. The group has only one reportable operating segment, which is the research, development, and commercialisation of pharmaceutical products.
9GF Score

Get the complete analysis for HKSE:02659

Notes Receivable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$15.94
Price